Transcatheter aortic valve replacement (TAVR) has become a mainstay in treatment for
patients with severe aortic stenosis who are considered high-risk surgical candidates. The …

Aortic valve stenosis (AS) is the most common valvular pathology and has traditionally been
managed using surgical aortic valve replacement (SAVR). A large proportion of affected …

In the last 15 years, transcatheter aortic valve implantation (TAVI) technology has met with
rapid uptake, with> 350,000 procedures performed in> 70 countries. Over the same period …

Transcatheter therapies for the treatment of structural heart diseases (SHD) have expanded
dramatically over the last years, thanks to the developments and improvements of devices …

AimTechnological and computational advancements offer new tools for the collection and
analysis of real-world data (RWD). Considering the substantial effort and resources devoted …

Background Arterial tortuosity is linked to a higher risk of adverse clinical events after
transfemoral transcatheter aortic valve replacement (TF‐TAVR). Currently, there are no …

Background The carotid artery is a novel access route for transcatheter aortic valve
implantation (TAVI), especially useful in patients unsuitable for traditional access routes …

Background: The transfemoral (TF) route is the gold-standard access for transcatheter aortic
valve replacement (TAVR). In 10–15% of patients, alternative accesses are needed, such as …

Background The choice of an alternative access for transcatheter aortic valve replacement
(TAVR) remains controversial when transfemoral (TF) access is not feasible. Methods We …

Background The use of bioprostheses for surgical aortic valve replacement increased
substantially within the last years. In case of prosthesis failure, re-SAVR is standard of care …